Synthetic Biologics (AMEX:SYN) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Synthetic Biologics reported in-line EPS of $-0.03 versus an estimate of $-0.03.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 37.56% increase in the share price the next day.
To track all earnings releases for Synthetic Biologics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
